Myriad Genetics Inc
MYGN3.915USD
+0.005+0.13%
取引時間 （ET）15分遅れの株価
360.96M時価総額
損失額直近12ヶ月PER
詳細情報 Myriad Genetics Inc 企業名
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight, among others.
企業情報
企業コードMYGN
会社名Myriad Genetics Inc
上場日Oct 06, 1995
最高経営責任者「CEO」Mr. Samraat S. (Sam) Raha
従業員数2700
証券種類Ordinary Share
決算期末Oct 06
本社所在地322 North 2200 West
都市SALT LAKE CITY
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号84116
電話番号18015843600
ウェブサイトhttps://myriad.com/
企業コードMYGN
上場日Oct 06, 1995
最高経営責任者「CEO」Mr. Samraat S. (Sam) Raha
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Brian Donnelly
Mr. Brian Donnelly
Chief Commercial Officer
Chief Commercial Officer
397.53K
--
Mr. Mark S. Verratti
Mr. Mark S. Verratti
Chief Operating Officer and Chief Commercial Officer
Chief Operating Officer and Chief Commercial Officer
221.65K
-11.52%
Dr. Lee Nisley Newcomer, M.D.
Dr. Lee Nisley Newcomer, M.D.
Independent Director
Independent Director
132.14K
+60.47%
Ms. Margaret (Maggie) Ancona
Ms. Margaret (Maggie) Ancona
Senior Vice President, Chief of Staff
Senior Vice President, Chief of Staff
128.68K
+56.61%
Ms. Rashmi Kumar
Ms. Rashmi Kumar
Independent Director
Independent Director
127.19K
+64.34%
Ms. Shereen Solaiman
Ms. Shereen Solaiman
Chief People Officer
Chief People Officer
110.96K
+98.89%
Dr. Dale Muzzey
Dr. Dale Muzzey
Chief Scientific Officer
Chief Scientific Officer
45.88K
-46.96%
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Matt Scalo
Mr. Matt Scalo
Investor Relations
Investor Relations
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Chief Legal Officer
Chief Legal Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Brian Donnelly
Mr. Brian Donnelly
Chief Commercial Officer
Chief Commercial Officer
397.53K
--
Mr. Mark S. Verratti
Mr. Mark S. Verratti
Chief Operating Officer and Chief Commercial Officer
Chief Operating Officer and Chief Commercial Officer
221.65K
-11.52%
Dr. Lee Nisley Newcomer, M.D.
Dr. Lee Nisley Newcomer, M.D.
Independent Director
Independent Director
132.14K
+60.47%
Ms. Margaret (Maggie) Ancona
Ms. Margaret (Maggie) Ancona
Senior Vice President, Chief of Staff
Senior Vice President, Chief of Staff
128.68K
+56.61%
Ms. Rashmi Kumar
Ms. Rashmi Kumar
Independent Director
Independent Director
127.19K
+64.34%
Ms. Shereen Solaiman
Ms. Shereen Solaiman
Chief People Officer
Chief People Officer
110.96K
+98.89%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
事業別USD
会社名
収益
比率
Hereditary Cancer
86.30M
44.05%
Prenatal
49.30M
25.17%
Pharmacogenomics
31.00M
15.82%
Tumor Profiling
29.30M
14.96%
地域別USD
会社名
収益
比率
United States
181.60M
92.70%
Rest of world
14.30M
7.30%
事業別
地域別
事業別USD
会社名
収益
比率
Hereditary Cancer
86.30M
44.05%
Prenatal
49.30M
25.17%
Pharmacogenomics
31.00M
15.82%
Tumor Profiling
29.30M
14.96%
株主
更新時刻: Thu, May 15
更新時刻: Thu, May 15
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
15.02%
The Vanguard Group, Inc.
10.04%
State Street Global Advisors (US)
5.72%
Disciplined Growth Investors, Inc.
5.14%
Wellington Management Company, LLP
4.98%
Other
59.10%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
15.02%
The Vanguard Group, Inc.
10.04%
State Street Global Advisors (US)
5.72%
Disciplined Growth Investors, Inc.
5.14%
Wellington Management Company, LLP
4.98%
Other
59.10%
種類
株主統計
比率
Investment Advisor
47.03%
Investment Advisor/Hedge Fund
31.99%
Hedge Fund
18.89%
Research Firm
3.85%
Individual Investor
3.25%
Pension Fund
1.35%
Bank and Trust
0.41%
Sovereign Wealth Fund
0.07%
Insurance Company
0.04%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
514
98.55M
106.92%
-3.88M
2025Q1
527
99.14M
107.57%
-4.54M
2024Q4
516
96.89M
106.12%
-1.41M
2024Q3
505
95.02M
104.61%
-5.50M
2024Q2
486
96.79M
106.52%
-6.22M
2024Q1
460
98.19M
108.68%
+613.48K
2023Q4
464
93.46M
105.77%
+2.70M
2023Q3
471
86.01M
104.78%
-3.73M
2023Q2
480
84.60M
103.32%
-6.34M
2023Q1
483
85.87M
105.37%
-2.69M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
13.85M
15.02%
-471.44K
-3.29%
Mar 31, 2025
The Vanguard Group, Inc.
10.62M
11.52%
+47.03K
+0.44%
Mar 31, 2025
State Street Global Advisors (US)
5.27M
5.72%
-256.92K
-4.65%
Mar 31, 2025
Disciplined Growth Investors, Inc.
4.73M
5.14%
+2.18M
+85.16%
Mar 31, 2025
Wellington Management Company, LLP
4.59M
4.98%
-1.41M
-23.52%
Mar 31, 2025
Millennium Management LLC
4.07M
4.41%
-275.67K
-6.34%
Mar 31, 2025
EARNEST Partners, LLC
3.98M
4.31%
+5.69K
+0.14%
Mar 31, 2025
Glenview Capital Management, LLC
3.90M
4.23%
-257.77K
-6.20%
Mar 31, 2025
D. E. Shaw & Co., L.P.
2.52M
2.74%
+702.80K
+38.62%
Mar 31, 2025
SEI Investments Management Corporation
2.42M
2.62%
-110.27K
-4.36%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
Global X Genomics & Biotechnology ETF
0.6%
WisdomTree BioRevolution Fund
0.6%
Invesco NASDAQ Future Gen 200 ETF
0.57%
Invesco S&P SmallCap Health Care ETF
0.35%
Federated Hermes MDT Small Cap Core ETF
0.3%
Strategas Global Policy Opportunities ETF
0.21%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.18%
SPDR S&P Biotech ETF
0.15%
Inspire Small/Mid Cap ESG ETF
0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
詳細を見る
Global X Genomics & Biotechnology ETF
比率0.6%
WisdomTree BioRevolution Fund
比率0.6%
Invesco NASDAQ Future Gen 200 ETF
比率0.57%
Invesco S&P SmallCap Health Care ETF
比率0.35%
Federated Hermes MDT Small Cap Core ETF
比率0.3%
Strategas Global Policy Opportunities ETF
比率0.21%
First Trust Nasdaq Lux Digi Health Solutions ETF
比率0.18%
SPDR S&P Biotech ETF
比率0.15%
Inspire Small/Mid Cap ESG ETF
比率0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.09%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
